Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17,527Revenue (TTM) $M23,371Net Margin (%)-25.2Altman Z-Score0.4
Enterprise Value $M57,214EPS (TTM) $-6.1Operating Margin %-18.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-23.9Higher ROA y-yN
Price/Book0.710-y EBITDA Growth Rate %6.8Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %-4.8Current Ratio0.9Lower Leverage y-yN
Price/Free Cash Flow5.5y-y EBITDA Growth Rate %-171.0ROA % (ttm)-6.9Higher Current Ratio y-yN
Dividend Yield %6.4PEG--ROE % (ttm)-19.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M1,016ROIC % (ttm)-7.3Gross Margin Increase y-yN

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

TEVA is held by these investors:



TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,0 Sep 22 2017 
    Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 23rd Lead Plaintiff Deadline in Clas Sep 21 2017 
    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceedi Sep 20 2017 
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. Sep 20 2017 
    TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC R Sep 15 2017 
    IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pha Sep 13 2017 
    IMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharm Sep 12 2017 
    Get a stock report on Alcoa, Ford, Health Insurance Innovations, Teva, Tesla Motors, or any stock yo Sep 12 2017 
    3 Stocks Climb as S&P Hits Record High Sep 12 2017 
    The Cooper Companies Announces Definitive Agreement to Acquire PARAGARD® IUD From Teva Sep 11 2017 

    More From Other Websites
    TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF... Sep 22 2017
    Generic Drug Makers Face Pricing Issues That Other Pharmas Don't Sep 22 2017
    Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : August 29th, 2017 (record date) :... Sep 21 2017
    EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical... Sep 21 2017
    Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Teva... Sep 21 2017
    Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 23rd Lead Plaintiff Deadline in... Sep 21 2017
    [$$] Teva Pharmaceutical Stock Could Double Sep 21 2017
    Our 5 Top Picks For A Booming Marijuana Market Sep 20 2017
    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses... Sep 20 2017
    INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva... Sep 20 2017
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd.... Sep 20 2017
    Teva/Nuvelution to Speed Up Development of Austedo in US Sep 20 2017
    [$$] States Push Ahead With Investigation Into Opioid Painkillers Sep 19 2017
    SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva... Sep 19 2017
    State attorneys general subpoena opioid makers and dealer... Sep 19 2017
    EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a... Sep 19 2017
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from... Sep 19 2017
    INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Teva... Sep 19 2017
    Teva shares rise on debt covenant amendments Sep 19 2017
    Teva and Nuvelution Pharma Partner to Accelerate Development of AUSTEDO® (deutetrabenazine) Tablets... Sep 19 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}